share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰制药 | 4：持股变动声明-高管 Bozic Carmen
美股sec公告 ·  05/31 16:33
Moomoo AI 已提取核心信息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Vertex Pharmicals Inc.（VRTX）执行副总裁兼首席营销官卡门·博齐奇于2024年5月29日完成了2,280股普通股的出售。该交易以每股445.56美元的价格执行，总销售价值约为1,015,876.80美元。出售后，Bozic在该公司的直接持股量为34,659股。据该公司最新文件所述，此次出售是通过公开市场交易进行的。
Vertex Pharmicals Inc.（VRTX）执行副总裁兼首席营销官卡门·博齐奇于2024年5月29日完成了2,280股普通股的出售。该交易以每股445.56美元的价格执行，总销售价值约为1,015,876.80美元。出售后，Bozic在该公司的直接持股量为34,659股。据该公司最新文件所述，此次出售是通过公开市场交易进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息